Browse By: Country ι Category ι Publisher ι Tag
Home  »  Patent Analysis

Patent Analysis Market Research Reports

Patent Analysis Market Research Reports & Industry Analysis at ResearchMoz
More

Amorolfine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Amorolfine - Key patent, SPC, and data exclusivity expiry (44 countries coverage) Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Amorolfine Amorolfine indications: Skin & nail fungal infections Amorolfine innovator: Galderma (Loceryl) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by countr
Published Date: May 2013
Published By: GenericsWeb

Price: $1200
Doripenem - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Doripenem - Key patent, SPC, and data exclusivity expiry (44 countries coverage) Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Doripenem Doripenem indications: Treatment of complicated intra-abdominal and urinary tract infections, including pyelonephritis. Doripenem innovator: Johnson & Johnson (Doribax) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term e
Published Date: May 2013
Published By: GenericsWeb

Price: $1200
Brimonidine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Brimonidine Brimonidine indications: Open-angle glaucoma, ocular hypertension Brimonidine innovator: Allergan (Alphagan, Enidin, Combigan) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, streng
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Loteprednol - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Loteprednol Loteprednol indications: Seasonal allergic conjunctivitis; Post-operative inflammation following cataract or ocular surgery; Steroid responsive inflammatory ocular conditions, optionally in combination with Tobramycin Loteprednol innovator: Bausch & Lomb (Alrex, Loteflam, Lotemax, Zylet) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC prot
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Mitiglinide - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Mitiglinide Mitiglinide indications: Improvement in and treatment of postprandial glucose transition, optionally in combination with a-glucosidase inhibitors, Metformin or thiazolidinediones, in patients with type 2 diabetes mellitus Mitiglinide innovator: Kissei (Glufast, Glubes); Elixir (Glinsuna, Metgluna) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cos
Published Date: Dec 2011
Published By: GenericsWeb

Price: $6400
Brinzolamide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Brinzolamide Brinzolamide indications: Ocular hypertension; Open angle glaucoma Brinzolamide innovator: Alcon (Azopt, Brinzoquin) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths,
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Metformin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Metformin Metformin indications: Diabetes; Polycystic ovary syndrome Metformin innovator: Merck (Glucophage); Alphapharm (Glucophage, Diabex); Bristol Myers Squibb (Glucophage); Depomed (Glumetza); Andrx Labs (Fortamet) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclus
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Modafinil - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Modafinil Modafinil indications: Excessive sleepiness associated with narcolepsy; obstructive sleep apnea/hyponea syndrome; shift work sleep disorder Modafinil innovator: Cephalon (Provigil); CSL (Modavigil); Draxis Health (Alertec) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceu
Published Date: Dec 2011
Published By: GenericsWeb

Price: $5600
Budesonide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Budesonide Budesonide indications: Treatment of hay-fever, nasal polyposis, inflammatory bowel disease, mild to moderate active Crohn\'s disease, allergic rhinitis, acute laryngotracheobronchitis and bronchial asthma. Budesonide innovator: AstraZeneca (Budamax, Entocort, Entocort EC, Pulmicort, Pulmicort Flexhaler, Pulmicort Respules, Pulmicort Turbuhaler, Rhinocort, Rhinocort Aqua, Rhinocort Hayfever, Symbicort); Dr Falk (Budenofalk); Meda (Novolizer)
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Metronidazole - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Metronidazole Metronidazole indications: Infections due to anaerobic pathogens; Urogenital trichomoniasis; Bacterial vaginosis; Rosacea Metronidazole innovator: Aventis (Flagyl); G D Searle (Flagyl); Pfizer (Metrozine) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusi
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Mometasone - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Mometasone Mometasone indications: Asthma, Allergic rhinitis, Inflammatory skin disorders Mometasone innovator: Schering (Elocon, Nasonex, Asmanex, Novasone, Metacort, Allermax, Uniclar, Bronconex Acticap) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams
Published Date: Dec 2011
Published By: GenericsWeb

Price: $5600
Caspofungin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Caspofungin Caspofungin indications: Empirical therapy for presumed fungal infections in febrile neutropenic patients; treatment of candidemia and selected Candida infections; treatment of esophageal candidiasis; treatment of invasive aspergillosis. Caspofungin innovator: Merck (Cancidas) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection fo
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Milnacipran - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Milnacipran Milnacipran indications: Fibromyalgia; Major depressive episodes Milnacipran innovator: Cypress (Savella); Pierre Fabre (Dalcipran, Ixel) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage form
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Montelukast - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Montelukast Montelukast indications: Asthma Montelukast innovator: Merck (Singulair); MSD (Singulair) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with no
Published Date: Dec 2011
Published By: GenericsWeb

Price: $5600
Celecoxib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Celecoxib Celecoxib indications: Familial adenomatous polyposis: rheumatoid arthritis: acute pain Celecoxib innovator: Pfizer (Celebrex, Onsenal): Gd Celecoxib (Genmed): Pharmacia (Celebrex): Searle (Celebrex) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivit
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Moxifloxacin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Moxifloxacin Moxifloxacin indications: Pneumonia, Chronic bronchitis, Sinusitis Moxifloxacin innovator: Bayer (Avelox); Alcon (Vigamox) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths,
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Moxifloxacin - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Moxifloxacin Moxifloxacin indications: Pneumonia, Chronic bronchitis, Sinusitis Moxifloxacin innovator: Bayer (Avelox); Alcon (Vigamox) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or
Published Date: Dec 2011
Published By: GenericsWeb

Price: $7200
Cetirizine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Cetirizine Cetirizine indications: Seasonal & perennial allergic rhinitis; Chronic urticaria Cetirizine innovator: McNeil (Zyrtec, Zyrtec-D, Benadryl); UCB (Zirtek, Zyrtec); Pfizer (Reactine) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated o
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Mycophenolic Acid - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Mycophenolic Acid Mycophenolic Acid indications: Prophylaxis of organ rejection Mycophenolic Acid innovator: Roche (Cellcept); Novartis (Myfortic) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms,
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Mycophenolic Acid - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Mycophenolic Acid Mycophenolic Acid indications: Prophylaxis of organ rejection Mycophenolic Acid innovator: Roche (Cellcept); Novartis (Myfortic) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted devel
Published Date: Dec 2011
Published By: GenericsWeb

Price: $5600
Cetuximab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Cetuximab Cetuximab indications: Colorectal cancer; Advanced squamous cell carcinoma of the head and neck Cetuximab innovator: Imclone (Erbitux) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage for
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Oseltamivir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Oseltamivir Oseltamivir indications: Treatment and prophylaxis of influenza Oseltamivir innovator: Roche (Tamiflu) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active ingr
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Naratriptan - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Naratriptan Naratriptan indications: Treatment of migraine Naratriptan innovator: GSK (Amerge, Naramig) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you w
Published Date: Dec 2011
Published By: GenericsWeb

Price: $6400
Ciprofloxacin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ciprofloxacin Ciprofloxacin indications: Urinary tract infections, bronchitis, sinusitis, cystitis, prostatitis, diarrhoea, typhoid, gonorrhoea corneal ulcers, superficial bacterial infections of the eye and adnexa. Ciprofloxacin innovator: Bayer (Cipro, Ciproxin) ; Alcon (Cipro, Ciloxan, Ciprodex) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Parecoxib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Parecoxib Parecoxib indications: Postoperative pain Parecoxib innovator: Pfizer (Dynastat) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active ingredient forms of the
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Nateglinide - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Nateglinide Nateglinide indications: Type 2 diabetes mellitus Nateglinide innovator: Novartis (Starlix) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you w
Published Date: Dec 2011
Published By: GenericsWeb

Price: $5600
Ciclosporin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ciclosporin Ciclosporin indications: Immunosuppressant; Prevention of graft rejection; Graft-versus-host disease; Atopic dermatitis; Psoriasis; Rheumatoid arthritis Ciclosporin innovator: Novartis (Neoral, Sandimmun); Allergan (Restasis); Abbott (Gengraf) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Raltegravir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Raltegravir Raltegravir indications: In combination with other antiretroviral agents for the treatment of HIV-1 infection Raltegravir innovator: Merck (Isentress) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Nebivolol - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Nebivolol Nebivolol indications: Essential hypertension Nebivolol innovator: Menarini (Nebilet) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with noth
Published Date: Dec 2011
Published By: GenericsWeb

Price: $4800
Darbepoetin alfa - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Darbepoetin alfa Darbepoetin alfa indications: Anaemia associated with chronic renal failure or chemotherapy Darbepoetin alfa innovator: Amgen (Aranesp) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of do
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Ramelteon - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ramelteon Ramelteon indications: Insomnia Ramelteon innovator: Takeda (Rozerem) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active ingredient forms of the brand produ
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Nicorandil - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Nicorandil Nicorandil indications: Angina Nicorandil innovator: Rhone-Poulenc Rorer (Ikorel); Chugai (Sigmart) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providin
Published Date: Dec 2011
Published By: GenericsWeb

Price: $4800
Desvenlafaxine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Desvenlafaxine Desvenlafaxine indications: Depression Desvenlafaxine innovator: Wyeth (Pristiq) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active ingredient forms of
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Rasagiline - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Rasagiline Rasagiline indications: Treatment of the signs and symptoms of idiopathic Parkinsons disease as initial monotherapy and as adjunct therapy to Levodopa. Rasagiline innovator: Teva (Azilect) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Octreotide - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Octreotide Octreotide indications: Acromegaly; Gastroentero-pancreatic endocrine tumours Octreotide innovator: Novartis (Sandostatin, Sandostatin LAR) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted d
Published Date: Dec 2011
Published By: GenericsWeb

Price: $5600
Doxercalciferol - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Doxercalciferol Doxercalciferol indications: Secondary hyperparathyroidism Doxercalciferol innovator: Genzyme (Hectorol) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and a
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Reboxetine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Reboxetine Reboxetine indications: Major depressive disorder Reboxetine innovator: Pharmacia (Edronax, Vestra); Pfizer (Edronax) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indicatio
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Olanzapine - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Olanzapine Olanzapine indications: Schizophrenia; Treatment of mania Olanzapine innovator: Eli Lilly (Zyprexa) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providin
Published Date: Dec 2011
Published By: GenericsWeb

Price: $5600
Drospirenone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Drospirenone Drospirenone indications: Prevention of pregnancy in women. Treatment of moderate to severe vasomotor symptoms and vulvar and vaginal atrophy associated with the menopause. Drospirenone innovator: Bayer (Angeliq, Yaz, Yasmin); Schering (Angeliq, Yasmin) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Remifentanil - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Remifentanil Remifentanil indications: Analgesic used during induction, maintenance and immediate postoperative period of general anaesthesia in combination with other anaesthetics; Analgesic component of monitored anaesthesia Remifentanil innovator: GlaxoSmithKline (Ultiva); Bioniche (Ultiva); Abbott Labs (Ultiva) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contain
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Olmesartan - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Olmesartan Olmesartan indications: Hypertension; Heart failure Olmesartan innovator: Sankyo (Benicar, Benicar HCT, Olmetec, Olmetec Plus, Azor); Pfizer (Olmetec, Olmetec Plus); Schering-Plough (Olmetec, Olmetec Plus) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies
Published Date: Dec 2011
Published By: GenericsWeb

Price: $7200
Duloxetine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Duloxetine Duloxetine indications: Major depressive disorder; Diabetic peripheral neuropathic pain; Generalized anxiety disorder; Stress urinary incontinence Duloxetine innovator: Eli Lilly (Cymbalta, Ariclaim, Yentreve) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exc
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Ribavirin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ribavirin Ribavirin indications: Hepatitis C (in combination with Interferon); Severe respiratory syncytial virus (RSV) bronchiolitis Ribavirin innovator: Roche (Copegus, Pegasys-RBV); Schering (Rebetol, Rebetron, Pegetron); Three Rivers Pharms (Ribasphere); Valeant Pharm (Virazole) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU sta
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Olopatadine - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Olopatadine Olopatadine indications: Treatment of allergic conjunctivitis Olopatadine innovator: Alcon (Patanol, Pataday, Opatanol) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or lega
Published Date: Dec 2011
Published By: GenericsWeb

Price: $5600
Dutasteride - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Dutasteride Dutasteride indications: Benign prostatic hyperplasia; treatment of symptomatic enlarged prostate Dutasteride innovator: GSK (Avodart, Avolve) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosa
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Ritonavir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ritonavir Ritonavir indications: Treatment of HIV infection Ritonavir innovator: Abbott (Norvir, Kaletra) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active ingredien
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Omega-3-acid ethyl esters - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Omega-3-acid ethyl esters Omega-3-acid ethyl esters indications: Adjuvant therapy for secondary prevention in post-myocardial infarction; management of hypertriglyceridaemia and mixed lipoprotein disorders. Omega-3-acid ethyl esters innovator: olvay (Omacor); Reliant (Lovaza, Omacor); Pronova (Omacor); Ferrer (Omacor) Imagine having your own team of pharmaceutical patent experts, at a fraction
Published Date: Dec 2011
Published By: GenericsWeb

Price: $10500
Efavirenz - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Efavirenz Efavirenz indications: Treatment of HIV-1 infection only in combination. Efavirenz innovator: Merck (Stocrin); Bristol-Myers Squibb (Sustiva, Atripla); Du Pont (Sustiva); Gilead Sciences (Atripla) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Rituximab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Rituximab Rituximab indications: Large B-cell non-Hodgkins lymphoma; Follicular lymphoma Rituximab innovator: Roche (MabThera); Genentech (Rituxan) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, s
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Omeprazole - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Omeprazole Omeprazole indications: Duodenal and benign gastric ulcers; Zollinger-Ellison syndrome; Gastro-oesophageal reflux disease Omeprazole innovator: AstraZeneca (Losec, Prilosec, Acimax, Nexium) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams,
Published Date: Dec 2011
Published By: GenericsWeb

Price: $6400
Enfuvirtide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Enfuvirtide Enfuvirtide indications: HIV-1 infection Enfuvirtide innovator: Roche (Fuzeon) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active ingredient for
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Rivaroxaban - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Rivaroxaban Rivaroxaban indications: Prevention of venous thromboembolism in adult patients who are undergoing elective hip or knee replacement surgery or who have undergone major orthopaedic surgery of the lower limps; Deep vein thrombosis; Pulmonary embolism Rivaroxaban innovator: Bayer (Xarelto) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Ondansetron - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Ondansetron Ondansetron indications: Emesis; Postoperative nausea and vomiting Ondansetron innovator: GlaxoSmithKline (Zofran) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal act
Published Date: Dec 2011
Published By: GenericsWeb

Price: $4800
Etravirine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Etravirine Etravirine indications: Treatment of HIV-1 in combination with other antiretroviral agents. Etravirine innovator: Janssen (Intelence); Tibotec (Intelence) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Rocuronium Bromide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Rocuronium Bromide Rocuronium Bromide indications: Muscle relaxant for surgery Rocuronium Bromide innovator: Organon (Zemuron, Esmeron) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, in
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Orlistat - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Orlistat Orlistat indications: Adjunct in obesity Orlistat innovator: Hoffman-La Roche (Xenical, Obix) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you wi
Published Date: Dec 2011
Published By: GenericsWeb

Price: $4800
Everolimus - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Everolimus Everolimus indications: Immunosuppresant to prevent rejection of organ transplants Everolimus innovator: Novartis (Certican) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, str
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Rufinamide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Rufinamide Rufinamide indications: Adjunctive treatment of seizures associated with Lennox-Gastaut syndrome Rufinamide innovator: Eisai (Banzel, Inovelon) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage f
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Oseltamivir - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Oseltamivir Oseltamivir indications: Treatment and prophylaxis of influenza Oseltamivir innovator: Roche (Tamiflu) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by prov
Published Date: Dec 2011
Published By: GenericsWeb

Price: $7200
Fesoterodine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Fesoterodine Fesoterodine indications: Treatment of the symptoms of overactive bladder syndrome. Fesoterodine innovator: Pfizer (Toviaz); Schwarz (Toviaz) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary o
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Saquinavir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Saquinavir Saquinavir indications: In combination with Ritonavir and other antiretroviral agents for the treatment of HIV/AIDS Saquinavir innovator: Roche (Invirase, Fortovase) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basi
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Oxaliplatin - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Oxaliplatin Oxaliplatin indications: Metastatic colorectal carcinoma Oxaliplatin innovator: Sanofi (Eloxatin) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing
Published Date: Dec 2011
Published By: GenericsWeb

Price: $6400
Formoterol - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Formoterol Formoterol indications: Asthma, Bronchospasms Formoterol innovator: Novartis (Foradil) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active ingredient
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Sibutramine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Sibutramine Sibutramine indications: Obesity Sibutramine innovator: Abbott (Reductil, Ectiva, Meridia) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active ingredient f
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Paclitaxel - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Paclitaxel Paclitaxel indications: Ovarian, breast and lung cancer. Kaposi\'s sarcoma. Paclitaxel innovator: Bristol Myers Squibb (Taxol) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments o
Published Date: Dec 2011
Published By: GenericsWeb

Price: $7200
Frovatriptan - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Frovatriptan . Frovatriptan indications: Treatment of migraine attacks with or without aura in adults. Frovatriptan innovator: Endo (Frova); Vernalis (Frova, Frovelan); Menarini (Migard) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a coun
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Silodosin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Silodosin Silodosin indications: Benign prostatic hypertropy Silodosin innovator: Kissei (Urief); Watson (Rapaflo) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Palonosetron - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Palonosetron Palonosetron indications: Prevention of nausea and vomiting (PONV) induced by emetogenic or cytotoxic chemotherapy; PONV for up to 24 hours following surgery Palonosetron innovator: Helsinn (Aloxi, Onicit); IS Pharm (Aloxi); Specialised Therap (Aloxi) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the
Published Date: Dec 2011
Published By: GenericsWeb

Price: $6400
Galantamine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Galantamine Galantamine indications: Treatment of mild to moderate dementia of the Alzheimer\'s type. Galantamine innovator: Janssen (Razadyne, Razadyne ER, Reminyl, Reminyl XL) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by c
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Sunitinib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Sunitinib Sunitinib indications: Gastrointestinal stromal tumour; advanced renal cell carcinoma Sunitinib innovator: Pfizer(Sutent) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indica
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Pantoprazole - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Pantoprazole Pantoprazole indications: Duodenal and benign gastric ulcers; Zollinger-Ellison syndrome; Gastro-oesophageal reflux disease Pantoprazole innovator: Wyeth (Protonix); Altana (Protium); Pfizer (Somac, Pantoloc Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical compan
Published Date: Dec 2011
Published By: GenericsWeb

Price: $5600
Hydroxychloroquine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Hydroxychloroquine Hydroxychloroquine indications: Malaria; lupus eythematosus; rheumatoid arthritis Hydroxychloroquine innovator: Sanofi Aventis (Plaquenil) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summar
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Tadalafil - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Tadalafil Tadalafil indications: Male erectile dysfunction, Impotence Tadalafil innovator: Lilly (Cialis) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active ingredien
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Paricalcitol - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Paricalcitol Paricalcitol indications: Secondary hyperparathyroidism associated with chronic kidney disease Paricalcitol innovator: Abbott (Zemplar) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted dev
Published Date: Dec 2011
Published By: GenericsWeb

Price: $4800
Ibandronic Acid - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ibandronic Acid Ibandronic Acid indications: Treatment and prevention of osteoporosis in postmenopausal women Ibandronic Acid innovator: Roche (Boniva, Bondronat) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis S
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Tapentadol - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Tapentadol Tapentadol indications: Moderate to severe acute pain Tapentadol innovator: Ortho McNeil Janssen (Nucynta) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Paroxetine - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface. This Pipeline Developer report covers Paroxetine Paroxetine indications: Depression illness; Obsessive-compulsive, panic, post-traumatic stress, and generalised anxiety disorders Paroxetine innovator: GlaxoSmithKline (Seroxat, Aropax, Paxil, Paroxat) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline
Published Date: Dec 2011
Published By: GenericsWeb

Price: $5600
Imatinib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Imatinib Imatinib indications: Chronic myeloid leukaemia; acute lymphoblastic leukaemia; Kit (CD117)-positive malignant gastro-intestinal stromal tumours (GIST); dermatofibrosarcoma protuberans Imatinib innovator: Novartis (Gleevec, Glivec) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Tazobactam - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Tazobactam Tazobactam indications: Nosocomial pneumonia; community-acquired pneumonia; appendicitis and peritonitis; skin and skin structure infections; infections caused by piperacillin-susceptible organisms; and postpartum endometritis or pelvic inflammatory disease Tazobactam innovator: Wyeth (Zosyn, Tazocin) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains S
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Pegfilgrastim - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Pegfilgrastim Pegfilgrastim indications: Decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia Pegfilgrastim innovator: Amgen (Neulasta) Imagine having your own team of pharmaceutical patent experts, at a fraction o
Published Date: Dec 2011
Published By: GenericsWeb

Price: $8250
Imiquimod - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Imiquimod Imiquimod indications: Anogenital warts; Superficial basal cell carcinoma Imiquimod innovator: 3M (Aldara) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Teicoplanin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Teicoplanin Teicoplanin indications: Gram-positive infections including endocarditis and peritonitis, Infections due to Staphylococcus aureus Teicoplanin innovator: Aventis (Targocid, Targosid) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a countr
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Pemetrexed - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface. This Pipeline Developer report covers PemetrexedPemetrexed indications: Non-small cell lung cancer; MesotheliomaPemetrexed innovator: Eli Lilly (Alimta)Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very be
Published Date: Dec 2011
Published By: GenericsWeb

Price: $6400
Iron Sucrose - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Iron Sucrose Iron Sucrose indications: Iron deficiency anemia Iron Sucrose innovator: Luitpold (Venofer); Syner-Med (Venofer); Baxter (Venofer); Aspen (Venofer) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Sum
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Penciclovir - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface. This Pipeline Developer report covers Penciclovir Penciclovir indications: Treatment of recurrent herpes labialis (cold sores). Penciclovir innovator: Novartis (Denavir, Vectavir) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by
Published Date: Dec 2011
Published By: GenericsWeb

Price: $6400
Isoniazid (Ext) - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Isoniazid (Ext) Isoniazid (Ext) indications: Pulmonary tuberculosis Isoniazid (Ext) innovator: Sanofi-Aventis (Rifamate, Rifinah) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indica
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Telmisartan - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Telmisartan Telmisartan indications: Hypertension Telmisartan innovator: Boehringer Ingelheim (Micardis, Micardis HCT, Micardis Plus, Pritor) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengt
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Pergolide - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Pergolide Pergolide indications: Parkinson\'s disease Pergolide innovator: Eli Lilly (Permax, Celance); Aspen (Permax) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by
Published Date: Dec 2011
Published By: GenericsWeb

Price: $4800
Ivermectin (Ext) - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ivermectin (Ext) Ivermectin (Ext) indications: Treatment and control of tapeworms, small and large strongyles, pinworms, Ascarids, hairworms, large-mouth stomach worms, bots, lungworms, intestinal threadworms, summer sores and dermatitis (horses). Ivermectin (Ext) innovator: Virbac (Equimax); Pfizer (Equimax); Merial (Zimecterin, Eqvalan); Centaur (Iverquantel) Examples of information found in this online report include: Includes key patent public
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Teriparatide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Teriparatide Teriparatide indications: Postmenopausal osteoporosis Teriparatide innovator: Lilly (Forteo, Forsteo) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Perindopril - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Perindopril Perindopril indications: Hypertension; Congestive heart failure Perindopril innovator: Servier (Coversyl, Coverex, Coversyl Plus, Coverex Combi, Preterax, Biprel, Perindo Combi); Solvay (Aceon) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal t
Published Date: Dec 2011
Published By: GenericsWeb

Price: $5600
Lacidipine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Lacidipine Lacidipine indications: Hypertension Lacidipine innovator: Boehringer Ingelheim (Motens) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active ingredient fo
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Tigecycline - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Tigecycline Tigecycline indications: Complicated skin and skin structure infections; Complicated intra-abdominal infections Tigecycline innovator: Wyeth(Tygacil) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of d
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Pioglitazone - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Pioglitazone Pioglitazone indications: Diabetes mellitus Pioglitazone innovator: Takeda (Actos); Eli Lilly (Actos) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by prov
Published Date: Dec 2011
Published By: GenericsWeb

Price: $6400
Lacosamide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Lacosamide Lacosamide indications: Partial-onset seizures Lacosamide innovator: Schwarz (Vimpat); UCB (Vimpat) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active in
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Tiotropium Bromide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Tiotropium Bromide Tiotropium Bromide indications: Bronchodilator, bronchospasm, chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema Tiotropium Bromide innovator: Boehringer Ingelheim (Spiriva, Favint) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data ex
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Pitavastatin - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Pitavastatin Pitavastatin indications: Hypercholesterolemia, antilipemic Pitavastatin innovator: Kowa (Livalo) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providin
Published Date: Dec 2011
Published By: GenericsWeb

Price: $6400
Lamivudine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Lamivudine Lamivudine indications: Treatment of HIV infections. Lamivudine innovator: GSK (Epivir, Zeffix, 3TC, Combivir, Trizivir, Epzicom, Kivexa) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Topotecan - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Topotecan Topotecan indications: Metastatic ovarian cancer; Small lung cell cancer sensitive disease Topotecan innovator: Merck (Hycamtin); GSK (Hycamtin) Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage f
Published Date: Dec 2011
Published By: GenericsWeb

Price: $1200
Posaconazole - Comprehensive patent search
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  This Pipeline Developer report covers Posaconazole Posaconazole indications: Duodenal and benign gastric ulcers; Zollinger-Ellison syndrome; Gastro-oesophageal reflux disease Posaconazole innovator: Wyeth (Protonix); Altana (Protium); Pfizer (Somac, Pantoloc) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical compa
Published Date: Dec 2011
Published By: GenericsWeb

Price: $7200